Citation Impact
Citing Papers
Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors
2010 Standout
Inflammasome is a central player in the induction of obesity and insulin resistance
2011
A comprehensive review of the genetics of juvenile idiopathic arthritis
2008
Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. Documento de consenso
2015
Atypical hemolytic uremic syndrome
2011
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura)
2017
Functional Bowel Disorders
2006 Standout
Gout-associated uric acid crystals activate the NALP3 inflammasome
2006 StandoutNature
Epidermal growth factor and transforming growth factor-β1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway
2007
Regulatory T cells exert checks and balances on self tolerance and autoimmunity
2009 StandoutNobel
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Human Genetics Shape the Gut Microbiome
2014 Standout
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic Syndrome
1998 Standout
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Risk Factors for Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Enterobacteriaceae –A Case–Control Study in a Low Prevalence Country
2013
Prevention of Amyloidosis in Familial Mediterranean Fever with Colchicine: A Case-Control Study in Armenia
2009
Anti-complement-factor H-associated glomerulopathies
2016
Pyrin Activates the ASC Pyroptosome in Response to Engagement by Autoinflammatory PSTPIP1 Mutants
2007
Familial Mediterranean Fever
2012 Standout
Cerebral vasculitis and intracerebral hemorrhage in Henoch-Sch�nlein purpura treated with plasmapheresis
2004
Juvenile idiopathic arthritis
2007 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Diagnostic and treatment concerns in familial Mediterranean fever
2000
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
2016
Contribution of the Endothelium to the Glomerular Permselectivity Barrier in Health and Disease
2007
Liver-Kidney Transplantation to Cure Atypical Hemolytic Uremic Syndrome
2008
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Familial autoinflammatory diseases: genetics, pathogenesis and treatment
2005
Pre-emptive Eculizumab and Plasmapheresis for Renal Transplant in Atypical Hemolytic Uremic Syndrome
2011
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
2009 StandoutNature
Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial
2011
Atypical Hemolytic–Uremic Syndrome
2009
Tolerance and Autoimmunity: Lessons at the Bedside of Primary Immunodeficiencies
2007
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Skin Cancers after Organ Transplantation
2003 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management
2017
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
From T to B and back again: positive feedback in systemic autoimmune disease
2001
The experience of pain and emergent osteoarthritis of the knee
2001
Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations
2006
Management of hemolytic uremic syndrome
2012
Mutation and Haplotype Studies of Familial Mediterranean Fever Reveal New Ancestral Relationships and Evidence for a High Carrier Frequency with Reduced Penetrance in the Ashkenazi Jewish Population
1999
Familial mediterranean fever with a single MEFV mutation: Where is the second hit?
2009
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?
2002 Standout
Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 Months
2011 Standout
The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
2009 Standout
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
2009 Standout
Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study
2006
A mouse model for Meckel syndrome reveals Mks1 is required for ciliogenesis and Hedgehog signaling
2009
Systemic amyloidosis
2015 Standout
Haemolytic uraemic syndrome
2017
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Chronic inflammation in FMF: markers, risk factors, outcomes and therapy
2010
Antibiotic resistance in the environment
2021 Standout
Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
2010
Functional mapping and annotation of genetic associations with FUMA
2017 Standout
Genetic Risk Factors of Amyloidogenesis in Familial Mediterranean Fever
2005
Skin diseases in children with organ transplants
2001
Neo‐ligands for innate immune receptors and the etiology of sterile inflammatory disease
2007 StandoutNobel
Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed
2004
Efficacy of colchicine therapy in amyloid nephropathy of familial Mediterranean fever
2003
A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases
2003
Mechanisms and Functions of Inflammasomes
2014 Standout
De novo thrombotic microangiopathy after non-renal solid organ transplantation
2014
Familial Mediterranean fever
2005
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
Antibiotics for acute pyelonephritis in children
2007
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Serum Proteomic Patterns Associated With Sleep-Disordered Breathing in Children
2006
Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases
2008 StandoutNobel
Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis
1999
Genetics of juvenile idiopathic arthritis: an update
2004
VEGF Inhibition and Renal Thrombotic Microangiopathy
2008 Standout
Low‐density Lipoprotein Apheresis in Children With Familial Hypercholesterolemia: Follow‐up to 21 Years
2008
Predominant Role of Host Genetics in Controlling the Composition of Gut Microbiota
2008
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Juvenile idiopathic arthritis genetics - what's new? What's next?
2002
The primary cilium: a signalling centre during vertebrate development
2010 Standout
Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis
2010
The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice
2011 Standout
Molecular Mechanisms of Amyloidosis
2003 Standout
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis
2003
Systemic AA Amyloidosis
2012
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Gut Microbiota in Health and Disease
2010 Standout
Atypical Hemolytic Uremic Syndrome: A Meta‐Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens
2017
Familial Mediterranean Fever (FMF) in Turkey
2005
Prospective study of Kawasaki disease complications: review of 115 cases
2011
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
Complement System Part II: Role in Immunity
2015
CATERPILLERs, pyrin and hereditary immunological disorders
2006
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
2004
Efficacy and safety of therapeutic plasma exchange by using apheresis devices in pediatric atypical hemolytic uremic syndrome patients
2015
Congenital and Infantile Nephrotic Syndrome
2013
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
2003 Standout
The Inflammasomes: Guardians of the Body
2009 Standout
Prospective study of Kawasaki disease complications: review of 115 cases
2011
Mechanisms of Diabetic Complications
2013 Standout
Antibiotics for acute pyelonephritis in children
2005
Thrombotic Microangiopathy with Targeted Cancer Agents
2011
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
Works of Nesrin Beşbaş being referenced
Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patients
2017
Tumour necrosis factor α G→A −238 and G→A −308 polymorphisms in juvenile idiopathic arthritis
2002
MEFV mutations in systemic onset juvenile idiopathic arthritis
2008
Comparative Study of Cefixime Alone Versus Intramuscular Ceftizoxime Followed by Cefixime in the Treatment of Urinary Tract Infections in Children
2001
Ataxia and peripheral neuropathy: rare manifestations in Henoch-Schönlein purpura
2001
Myelodysplastic features in juvenile rheumatoid arthritis
1997
Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children
2010
Post-transplant hypertension in pediatric kidney transplant recipients
2014
Plasma lipids and lipoproteins in juvenile chronic arthritis
1996
Anaemia in juvenile chronic arthritis
1996
The Role of Cytokines in Henoch Schonlein Purpura
1997
An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome
2014
Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab
2012
Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis
2008
Aberrant splicing is a common mutational mechanism inMKS1, a key player in Meckel-Gruber syndrome
2007
Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis
1997
Familial Mediterranean fever and amyloidosis in children
1993
Bone mineral density in children with familial Mediterranean fever
2004
Cytomegalovirus-related congenital nephrotic syndrome with diffuse mesangial sclerosis
2006
Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population
2001
Comparison of Ceftriaxone versus Cefotaxime for Childhood Upper Urinary Tract Infections
1996
Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
2015
A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders
2006
Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases
2015
Henoch-Schönlein purpura in Wiskott-Aldrich syndrome
2001
Interleukin-1, -6, and -8 levels in juvenile chronic arthritis
1997
Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis
2004
Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): A concomitant disease or a feature of FMF?
2001
Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.
2004
Peripheral Gangrene Associated with Kawasaki Disease and Successful Management Using Prostacycline Analogue: A Case Report
2007
Direct Adsorption of Lipoproteins from Whole Blood by Direct Adsorption of Lipoprotein Apheresis: First Experience in Two Hypercholesterolemic Children
2005
Upregulation of epidermal growth factor and its receptor in the kidneys of rats with streptozotocin-induced diabetes.
1997
Insulin-like growth factor-I and experimental diabetic kidney disease.
1994
Increased neutrophil apoptosis during attacks of familial Mediterranean fever.
2002
Survey of Turkish systemic lupus erythematosus patients for a particular mutation of C1Q deficiency.
2000
Th1 polarization in familial Mediterranean fever.
2003
Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch-Schönlein purpura.
1998
Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients.
2004
Familial Mediterranean fever patients homozygous for E148Q variant may have milder disease
2016
Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
2004
Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population.
2004
Kaposi sarcoma in a paediatric renal transplant recipient
1996
Genetic linkage study of familial Mediterranean fever (FMF) to 16p13.3 and evidence for genetic heterogeneity in the Turkish population.
1997
Sacroiliitis in familial Mediterranean fever: an unusual presentation in childhood.
2000
Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation?
2003